With a potential FDA approval on the horizon and promising pipeline progress, Precigen stands out as a hot biotech stock worth watching. Overall, PGEN ranks 4th on our list of hot biotech stocks ...

Lixte Biotechnology (NASDAQ:LIXT) stock is rocketing higher on Tuesday after the pharmaceutical company revealed pre-clinical results for one of its treatments. Source: CI Photos / Shutterstock ...

Let’s look at the reasons that make these unknown biotech stocks interesting. Nkarta (NASDAQ:NKTX) stock has been trending lower in the last 12 months. However, the unknown biotech stock holds ...

Photo Illustration: Sharon Shi Biotech companies are having one of their worst stock-market runs in years, as rising interest rates, scientific setbacks and a slowdown in big pharma buyouts batter ...

No one can know exactly which biotech stock will one-day reign supreme. But if you invest in many of them, you can play the averages. And a single winner can make up for a dozen losers.

The revenue potential for the three drug candidates makes Axsome Therapeutics an attractive biotech stock to consider buying in 2023. Exelixis has developed four drugs that are already on the market.

In the the case of Lixte Biotechnology, which is trading at $3.33 as of publishing time, $100 would buy you 30.03 shares of stock. If you're looking to bet against a company, the process is more ...